PACS Stock Analysis: Buy, Sell, or Hold?
PACS - PACS Group, Inc.
$33.14
-2.13 (-6.04%)
▼
5d:
-7.69%
30d:
+8.34%
90d:
-3.61%
HOLD
LOW Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: Feb 25, 2026
0d
Smart Money Accumulation
PACS is down 8.4% this week, but smart money is accumulating calls. Top strike: $45 2026-06-18 with 1,196 OI. Call ratio: 100% View Scanner →
Strength: 9.2/10
Get Alerted When PACS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PACS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: PACS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$59.83
Based on 8.1% avg growth
INTRINSIC VALUE TODAY
$37.15
10.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PACS is currently trading at $33.14, which is considered slightly low relative to its 30-day fair value range of $32.12 to $35.30. From a valuation perspective, the stock is trading at a discount (Forward PE: 14.0) compared to its historical average (17.2). Remarkably, the market is currently pricing in an annual earnings decline of 6.6% over the next few years. This pessimistic expectation contrasts with the company's recent 57.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PACS is in a downtrend. The price is currently testing key support at $32.26. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.0% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $45.83 (+38.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PACS is in a downtrend. The price is currently testing key support at $32.26. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.0% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $45.83 (+38.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$32.12 -
$35.30
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
Protect Your Profits
Holding PACS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.0%)
- BULLISH: Trading 38.3% below Wall St target ($45.83)
- CAUTION: Recommendation downgraded due to -7.7% 5-day decline
Trading Range Analysis
30-Day Trading Range
$32.12 -
$35.30
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$32.26
Resistance Level
$37.50
Current Trend
Downtrend
Technical data as of
Apr 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.04
Wall Street Target
$45.83
(+38.3%)
Revenue Growth (YoY)
12.4%
Earnings Growth (YoY)
57.2%
Profit Margin
3.6%
Valuation Discount vs History
-6.6% cheaper
PE vs Historical
14.0 vs 17.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.6%
(market-implied from PE analysis)
1-Year Target
$30.95
(-7%)
2-Year Target
$28.91
(-13%)
3-Year Target
$27.00
(-19%)
3-Yr Target (if PE normalizes)
(PE: 14→17)
$33.08
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.6, Growth: 12.2%)
$68.80
(+108%)
Base:
(SPY PE: 14.0, Growth: 12.2%)
$46.86
(+41%)
Bear:
(PE: 11.9, Growth: 12.2%)
$39.83
(+20%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (29x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 28.91 | Current EPS (TTM): $1.22
Bull Case
$75.07
(+127%)
Analyst growth 93.5%, PE expands to 31.8
Base Case
$68.24
(+106%)
Market implied 93.5%, PE stable at 28.9
Bear Case
$23.98
(-28%)
Severe decline -20.0%, PE contracts to 24.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 14.0 to 17.2
Stabilization Target:
$40.60
(+22.5%)
PE Expansion Potential:
+22.5%
Share & Embed Analysis
Last updated: April 29, 2026 2:42 AM ET
Data refreshes hourly during market hours. Next update: 3:42 AM
Data refreshes hourly during market hours. Next update: 3:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PACS showing a specific setup today?
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Joshua Jergensen
SELL
36335 shares
2026-03-13
Evelyn S Dilsaver
BUY
16724 shares
2025-11-24
John Todd Mitchell
SELL
159556 shares
2025-11-24
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$263 | 57 HOLD |
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$535 | 58 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$143 | 58 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 58 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$139 | 64 BUY |
Advanced PACS Option Strategies
Professional options setups generated by AI based on today's PACS price and gamma walls.
